Analytical Data
-
基因名
Dermatopontin/DPT
- Application
-
别名
TRAMP; Tyrosine-rich acidic matrix protein
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 95% as determined by SDS-PAGE.
-
蛋白编号
Q07507
-
表达区间
Pro26~Glu197
-
分子量
21kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Mucin-15 (MUC15) is a member of the mucin family, characterized by its high molecular weight and special glycosylation patterns that confer unique biological functions. Research into MUC15 has gained interest due to its potential roles in tumor biology, cell signaling, and immune responses. Originally identified in various epithelial tissues, MUC15 is believed to contribute to the maintenance of mucosal barriers and modulate cell adhesion processes. Its aberrant expression has been implicated in several cancers, making it a promising target for therapeutics and diagnostics. The recombinant production of MUC15 protein allows for detailed studies into its structure-function relationships and biological activities. By investigating MUC15 through recombinant techniques, researchers can better understand its role in pathological conditions, explore its function in cellular interactions, and evaluate its potential as a biomarker for cancer diagnosis and prognosis. Furthermore, studying MUC15 in a controlled environment aids in the development of targeted therapies that could enhance treatment strategies for cancer patients. Overall, the exploration of MUC15/MUC15 recombinant protein not only advances our understanding of mucin biology but also opens avenues for innovative clinical applications.
